![]()
MIRA INFORM REPORT
|
Report Date : |
29.11.2011 |
IDENTIFICATION DETAILS
|
Correct Name : |
ALGERIAN GENERIC DEVELOPPMENT SARL |
|
|
|
|
Registered Office : |
2, Rue Mohamed
Tahar Souag Hydra, Alger |
|
|
|
|
Country : |
Algeria |
|
|
|
|
Date of Incorporation : |
12.03.1998 |
|
|
|
|
Com. Reg. No.: |
98 B4371 |
|
|
|
|
Legal Form : |
Societe Anonyme Responsabilite Limitee |
|
|
|
|
Line of Business : |
dealers in
pharmaceuticals and related facilities |
|
|
|
|
No. of Employees
: |
10 Persons |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 50,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30th, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Algeria |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Registered Name: ALGERIAN GENERIC DEVELOPPMENT SARL
Requested Name: AGD
PHARMA
Trade Names: AGD
PHARMA
Physical Address: 2,
Rue Mohamed Tahar Souag Hydra, Alger
Postal Address: 2,
Rue Mohamed Tahar Souag
Hydra, Alger
Country: Algeria
Phone: 213-21298077
Fax: 213-21688217
Email: agdpharma2009@yahoo.fr
Website: None
Financial Index as of December 2010 shows subject firm with a medium
risk of credit. However, bank and credit information obtained reveal a history
of prompt payments. We recommend Credit of USD 50,000 on 90 days.
Legal Form: Societe
Anonyme Responsabilite Limitee.
Date Incorporated: 12/03/1998
Reg. Number: 98 B4371
Nominal Capital DZD. 6,000,000
Subscribed Capital DZD. 6,000,000
Subscribed Capital is Subscribed in the following form:
Position Shares
Mr. Toufik Aitali MD
Mr. Yacine Nabi Director
None Parent company.
None Subsidiary company.
None Affiliated company.
None Shareholder of subject firm.
None Branches of the firm
Registered to operate as dealers in pharmaceuticals and related
facilities
Imports: Asia,
Europe
Exports: None
Trademarks: None
Terms of sale: Cash
(40%) and 25-90 days (60%), invoices.
Main
Customers: firms and
organizations
Employees: 10 employees.
Vehicles: Several motor
vehicles.
Territory
of sales: Algeria
Location: Rented/ Owned
premises, 2.000 square feet,
Auditors: Information not available.
Insurance
Brokers: Information not available.
Currency Reported: Algerian Dinar (DZD.)
Approx. Ex. Rate: 1 US Dollar = 73.97 Algerian Dinar
Fiscal
Year End: December 31, 2010
Inflation: According to
information given by independent sources, the
inflation at December 31st, 2010 was of
13%.
Financial
Information not Submitted
Profit and Loss (expressed in DZD.)
2010
Sales 50,000,000
Bank Name: CCF Bank, Algeria
Branch: Algeria
Comments: Overdraft None, Promissory notes- None
Experiences: Good
None
This information was obtained from outside sources other than the
subject company itself and confirmed the above subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.98 |
|
UK Pound |
1 |
Rs.80.59 |
|
Euro |
1 |
Rs.69.12 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.